mesothelioma

Sarcomatoid Mesothelioma Treatment

Sarcomatoid mesothelioma is the least common histological type of mesothelioma, but it is the most aggressive. http://www.ncbi.nlm.nih.gov/pubmed/20081811?dopt=Abstract Even more than epithelial mesothelioma, the sarcomatoid form is difficult to diagnose and to distinguish from other diseases. Just looking at the cells under a microscope is not enough, and doctors employ immunohistological tests to distinguish Sarcomatoid mesothelioma

Sarcomatoid Mesothelioma Treatment Read More »

Epithelial Mesothelioma – Clinical Presentation and Diagnosis

Epithelial (or epithelioid) mesothelioma is the most common histological type of mesothelioma.  Epithelial mesothelioma is a subtype – both pleural and peritoneal mesothelioma may be epithelial or sarcamatoid or biphasic (including both cell types.) Epithelial mesothelioma has a better prognosis than other subtypes.  Average life expectancy after diagnosis is longer. As with all types of mesothelioma, asbestos

Epithelial Mesothelioma – Clinical Presentation and Diagnosis Read More »

Diagnosing Epithelial Mesothelioma

Performing a concurrent bronchoscopy may be vital for making a differentiation between mesothelioma and metastatic adenocarcinoma of the lung, since endobronchial lesions are seldom seen in mesothelioma. A new approach to differentiate between mesothelioma and adenocarcinoma of the lung is currently under development. This new approach relies on gene expression profiling, by identifying specific genes

Diagnosing Epithelial Mesothelioma Read More »

World’s First Cancer-Killing Pill May be Available Within the Decade

Thanks to advancement made possible through the Human Genome Project, British researchers believe the world’s first cancer-killing pill may be on the horizon. According to the team’s timeline, such a pill may be available in as few as ten years. The success of this future pill will work by exploiting a specific gene flaw that

World’s First Cancer-Killing Pill May be Available Within the Decade Read More »

New Diagnostic Technique Could Result in Test for Mesothelioma

Reuters is reporting a new blood test that could identify mesothelioma at an early stage. The biotech company Somalogic, which specializes in developing diagnostic tests, announced a new technology that could allow doctors to identify mesothelioma in patients before they show visible symptoms. Somalogic scientists used blood samples from mesothelioma patients and were able to

New Diagnostic Technique Could Result in Test for Mesothelioma Read More »

Improving Adoption Rates of Orphan Drugs for Mesothelioma and Other Rare Diseases

Recently, research on a promising drug for a disease that currently affects 1,500 people in the United States annually was halted due the financial reasons, according to Peter Saltonstall of the National Organization for Rare Diseases. The root of these financial reasons stems from the cost of research versus the expected amount of profits that

Improving Adoption Rates of Orphan Drugs for Mesothelioma and Other Rare Diseases Read More »

Mesothelioma in Pets Can Provide Insight Into New Treatments

Mesothelioma is a rare type of cancer that accounts for approximately one percent of all cancer deaths worldwide. The cancer is caused through the inhalation of asbestos – a naturally occurring fiber that is often used for insulation or heat-resistant purposes. Just as asbestos exposure affects human health, so too does it affect the health

Mesothelioma in Pets Can Provide Insight Into New Treatments Read More »